Booster Innovation Fund logo

BIF – Quarterly Client Update

Quarterly Update12 April 2024BIFFinancials

Booster Innovation Fund
Quarterly Client Update

Update as at and for the quarter ending 31 March 2024

Booster Innovation Scheme

Portfolio Performance

The Booster Innovation Fund (BIF) has had a

positive quarter ending 31 March 2024, returning

1.3% for the quarter and 18.0% p.a. since inception

(24 August 2021) (after fees and before tax).

There have been valuation movements in several of

the companies invested in, with some experiencing

uplifts in response to their business and investment

activities, and others adjusted downwards to

reflect slower than expected progress.

As at the end of March, the Booster Innovation Fund

has equity/equity-like assets and cash of $19.5m.

Portfolio Additions and Exits

During the quarter, BIF invested $0.85m, securing

interests in three new companies, The Sustainable Care

Company Limited (trading as Cleanery), My Better

Breathing Limited (trading as Good Air Nosebuds),

and Wellumio Limited and providing follow on

investment into two existing portfolio companies,

Opo Bio Limited and Woolchemy NZ Limited.

Cleanery sells a range of eco-friendly cleaning and

personal care products that aim to have a reduced

environmental impact compared to existing solutions.

It was established in 2017 and has developed unique

cleaning solutions that are sold in powder form,

reducing the reliance on single use plastics.

Good Air Nosebuds is developing a patented

mechanical breathing technology. The nose buds

provide a non-invasive, non-drug, nasal congestion

solution, which allows natural function and

improved nasal patency (how open the nose is).

Wellumio was established to commercialise a unique,

world-first, portable magnetic resonance imaging (MRI)

device. The company was established in September

2019 and the team is aiming to revolutionise the stroke

treatment model to offer diagnosis in the critical

‘golden hour’ (first hour following the stroke) by

bringing brain scans to where the stroke happens.

During the quarter, one company has been formally

placed into Liquidation, PowerOn Limited. This has

been a difficult time for the PowerOn team as the

reality of business progress and challenging market

conditions have affected the ability of the company to

succeed. While outcomes like this are disappointing,

we accept that they are a natural part of investing

in early stage businesses. The fund’s returns since

inception show that overall the impact of these

closures has been more than offset by portfolio

diversity and gains in value by other holdings.

Fund Size

(net asset value)

$19.5 million

Inception Date 24/08/2021

ManagerBooster Investment Management Ltd

SupervisorPublic Trust

Fund TypePortfolio Investment Entity (PIE)

Key Facts

Before TaxAfter Tax (28%)

Last 3 months1.3% 1.3%

Last 6 months-0.5%-0.8%

Last 12 months9.9%9.6%

Last 2 years (p.a.)11.9%11.9%

Since Inception

24/8/21 (p.a.)

18.0%18.6%

Performance as at 31 March 2024

BIF was created in August 2021. Potential returns

on early stage businesses are uncertain, difficult

to predict and can range widely both positively

and negatively. By taking a portfolio approach to

investing, the Booster Innovation Fund aims to deliver

a significant total rate of return over rolling 15-year

periods. Past performance is not an indicator of future

performance.

All figures are after fees. Please see the Product Disclosure Statement for

further details.

After tax return may be higher than before tax due to tax credits from

performance based fees.

Portfolio Spotlight
As the portfolio grows and matures, so do many of the portfolio

companies within it. The companies we have invested in are typically

working towards creating meaningful change on a global scale. Here are

a few recent examples that showcase some of the excitement that these

portfolio companies are creating.

For a third year now, companies in the portfolio will be recognised at the

prestigious New Zealand Hi-tech awards. Congratulations to MACSO,

who develop human-like sensors for remote monitoring who are a finalist

in two award categories, the Most Innovative Deep Tech Solution and the

Most Innovative Hi-tech Agritech Solution awards.

Congratulations to two more companies who are being recognised for

their contributions to address global environmental challenges. They are

nominees for the International Earthshot Prize which provides five prizes

worth nearly NZ$2m each and awarded by the Royal Foundation of the

Duke and Duchess of Cambridge. New Zealand’s only official nominator,

Victoria University of Wellington nominated Hot Lime Labs as one of its

five nominees. Hot Lime Labs achieved a major milestone this quarter,

with the installation of its first commercial scale system. This represents

the initial commercial supply of CO2 to a commercial greenhouse which

is sourced from biomass waste streams, proving their potential to supply

onsite, renewable CO2 for the greenhouse industry.

B.Spkl, the second company, was nominated by the international

Cleantech Group for the International Earthshot Prize. B.Spkl has been

gaining international recognition as they also featured at the Hello

Tomorrow Global Summit as one of seven finalists in the Energy track

Global Challenge and one of 70 finalists (across 10 categories). They were

selected from 4,000+ applications to pitch at the international forum to

over 1,500 industry leaders and investors.

Portfolio value by sector

16% Information services technology

32% Materials & technologies

24% Life sciences & medical

technologies

26% Energy & clean technologies

2% Cash

BIF Investment Holdings

BIF holds interests in a portfolio of over 35 investments with a total value of $19.5m, across a range of business

sectors as follows. We intend to grow a more diversified portfolio, indicatively more than 40.

Part of the fund’s investments are held by investing in NZ Innovation Booster LP (NZIB). For further information of how we invest through NZIB

refer to the Product Disclosure Statement on the booster.co.nz website.

Potentially lower returns Potentially higher returns

Higher risk

Lower risk

Risk Level

Early stage company investing is generally

considered the riskiest type of equity investing.

While the fund is not required to calculate a Risk

Indicator based on the volatility of the fund (being

the extent to which the fund’s assets go up and

down), we consider the fund’s risk rating would

equate to 7 on a scale of 1 (low) to 7 (high).

Please see the Product Disclosure Statement for a description

of the circumstances that the manager is aware of that exist or

are likely to arise that significantly increase the risk to returns

for investors in the Booster Innovation Fund.

Continued on the next page.
Description of Individual Holdings

Company


Company StageDescription

Advemto Limited

1

Early stage

Sell ultrafast spectroscopy systems, that can reduce research analysis

from months to days.

Alimetry Limited

1,2

Expansion

Sell non-invasive devices for aiding informed diagnostics for gastric

disease.

Allegro Energy Pty Limited

1

Early stage

Developing high performance water-based electrolytes provide a low

cost, clean and green energy storage solution.

Amaroq Therapeutics

Limited

1

Seed

Developing a new class of therapeutics that target long non-coding RNA

in cancer.

Avasa LimitedSeed

Commercialising a novel implantable medical device that aids in complex

microvascular artery and vein reconstruction.

BioLumic IncExpansion

Improves crop yield and quality by treating seeds and seedlings with UV-

light recipes.

B.spkl LimitedSeed

Commercialising a unique manufacturing method and materials

technology to produce a key component of hydrogen electrolysers,

aiming to facilitate viable green hydrogen production.

Calocurb LimitedEarly stage

Developing a bioactive ingredient, sourced from New Zealand hops,

to assist people with chronic and debilitating obesity, a growing health

epidemic internationally.

Captivate Technology

Limited

Seed

Developing a novel method of carbon capture, with potential to

sequester greenhouse gas emissions across a range of industries.

Codify Asset Solutions

(CAS) Limited

1,2,3

Early stage

Sell software that automates compliance, management, and auditing of

infrastructure assets.

Chitogel Limited

1

Expansion

Sell sinus dressings that helps to enhance wound healing and improve

patient outcomes post-surgery.

Ferronova Pty Limited

1

Expansion

Developing surgical tracer systems that are designed to more accurately

map cancer spread to lymph nodes.

Hot Lime Labs LimitedEarly stage

Developing carbon capture systems to convert wood biomass into a

more sustainable source of CO2 for use in horticulture.

Inhibit Coatings Limited

1

Early stage

Developing coatings to inhibit microbial contamination and outbreaks in

facilities with high hygiene requirements.

InsituGen Limited

1

Expansion

Developing testing solutions for the detection of performance enhancing

drug use in animals and humans.

Jaipuna Limited

3


(trading as Amy.app)

Early stage

Providing an online private tutor for maths that makes learning maths

easy for everyone.

Komodo Holdings LimitedEarly stage

Helping teachers and schools track the wellbeing of students using an

interactive wellbeing platform.

Liquium Limited

1

Seed

Seeking to revolutionise the ammonia production process making it

cleaner, cheaper and scalable.

MACSO Technologies

Limited

Seed

Developing cloud based monitoring systems utilising human-like sensors

and on-edge artificial intelligence to monitor changes in the built

environment.

The Booster Innovation Fund (fund) is part of the Booster Innovation Scheme which is issued and managed by Booster Investment Management Ltd (Booster).
The fund’s Product Disclosure Statement is available at www.booster.co.nz, by contacting your financial adviser or by calling Booster on 0800 40 40 50.

Disclaimer: This document is for information purposes only. The information is derived from sources believed to be accurate as at the date of issue and may change.

The content is of a general nature and does not take into account your financial situation or goals and is not financial advice. Booster, its related companies, directors,

board members and nominees do not accept any liability for any loss or damage arising directly or indirectly out of the use of, or reliance on, the information provided

in this document, nor do they guarantee the fund’s performance, returns or repayment of capital.


Companies that have advised the Manager that they have been put into liquidation (and the Manager has valued at nil) are not included. This quarter has seen one

company meet this classification; PowerON Limited.

1 Investments are held indirectly via an interest in NZIB.

2 Investments are held indirectly via NZIB which has an interest in the specific investees through an agreement with the Matū Karihi fund.

3

Companies have advised the Manager that it is currently in hibernation. The Manager has adjusted down the valuation accordingly.

For more information visit “The BIF Story” at our website.

Marama Labs Limited

1

Early stage

Develops scientific hardware and data analytics solutions to help

wineries improve the quality of their wine production.

Mekonos Inc

1,2

Expansion

Developing silicon chips, with hundreds of moving nano-needles, to help

improve drug development and drug delivery to patients.

Montoux LimitedExpansion

Provides an actuarial Automation and Decision Science platform

specifically designed for life and health insurers

My Better Breathing Limited

(trading as Good Air

Nosebuds)

Seed

Developing a mechanical breathing technology to improve natural

function and reduce nasal congestion.

Opo Bio LimitedSeed

Produces living and non-living ingredients for the production of the fast

growing cultivated meats sector.

Orbis Diagnostics LimitedEarly stage

Developing point of care diagnostics for use in pharmacy and other

settings.

Scentian Bio LimitedEarly stage

Commercialising a unique sensing system, based on insect sensing

receptors, that can define a digital reference for a taste and smell.

Sensor Holdings Limited

(trading as StretchSense)

Expansion

Sell motion capture gloves that combine sensors and machine learning

for finger tracking in animation and gaming.

TamoRx LimitedSeed

Specialise in the development of novel drugs which arm the immune

system to help fight cancer.

TasmanIon Limited

1

Seed

Developing aluminium-ion battery technologies suited for grid storage

and portable applications.

The Sustainable Care

Company (trading as

Cleanery)

Expansion

Sell a range of eco-friendly cleaning and personal care products that aim

to have a reduced environmental impact compared to existing solutions.

Upstream Medical

Technologies Limited

1

Early stage

Developing novel cardiac biomarkers to diagnose specific heart

conditions rapidly and accurately.

Wellumio Limited

1

Seed

Developing portable, magnetic resonance imaging (MRI) device to

improve stroke treatment model.

Woolchemy NZ LimitedEarly stage

Utilising wool to create intelligent eco-logical materials for personal care

products.

Whole Fish Limited

(trading as New Fish)

Seed

Developing marine whey, a protein source produced from water and

microalgae.

XFrame Pty Limited

1

ExpansionSell recoverable, reusable building frames for sustainable construction.

ZeroJet LimitedExpansion

Selling electric jet propulsion systems, seeking to eliminate the need for

combustion engines on small watercraft.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.